Plain-English translation of NCT07390279 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing transcutaneous pulsed radiofrequency (TCPRF), a non-invasive technique that uses electrical energy applied through adhesive skin patches to reduce chronic nerve pain caused by shingles. The study will measure whether this treatment helps people whose pain has not gotten better with standard medications. Researchers will track pain levels and quality of life over three months to see if this treatment works.
Many people continue to suffer from severe, long-lasting nerve pain after shingles even when taking pain medications. This trial exists to see if this newer, non-invasive electrical treatment might offer relief for those whose pain doesn't improve with conventional approaches.
You likely qualify if…
You likely don't qualify if…
You will receive the transcutaneous pulsed radiofrequency treatment applied as adhesive patches to your skin over the painful area—no needles or surgery involved. After the treatment, you will have follow-up visits at 1 month and 3 months where you will answer questions about your pain levels and how you are feeling. The entire study lasts about six months.
AI-generated summary from trial data · Jul 19, 2026 · Not medical advice
Turkey (Türkiye)